β₂ Agonist for the Treatment of Acute Lung Injury: A Systematic Review and Meta-analysis

References

1. 1.↵
   1. Perina DG

   . Noncardiogenic pulmonary edema. Emerg Med Clin North Am 2003;21(2):385-393.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Sartori C,
   2. Allemann Y,
   3. Duplain H,
   4. Lepori M,
   5. Egli M,
   6. Lipp E,
   7. et al

   . Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002;346(21):1631-1636.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Matthay MA,
   2. Folkesson HG,
   3. Clerici C

   . Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002;82(3):569-600.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Ware LB,
   2. Matthay MA

   . Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163(6):1376-1383.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. McAuley DF,
   2. Frank JA,
   3. Fang X,
   4. Matthay MA

   . Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med 2004;32(7):1470-1476.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Lee JW

   . beta2 adrenergic agonists in acute lung injury? The heart of the matter. Crit Care 2009;13(6):1011.

   OpenUrlPubMed
7. 7.↵
   1. Manocha S,
   2. Gordon AC,
   3. Salehifar E,
   4. Groshaus H,
   5. Walley KR,
   6. Russell JA

   . Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury. Crit Care 2006;10(1):R12.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Bassford CR,
   2. Thickett DR,
   3. Perkins GD

   . The rise and fall of beta-agonists in the treatment of ARDS. Crit Care 2012;16(2):208.

   OpenUrlPubMed
9. 9.↵
   1. Perkins GD,
   2. McAuley DF,
   3. Richter A,
   4. Thickett DR,
   5. Gao F

   . Bench-to-bedside review: beta2-Agonists and the acute respiratory distress syndrome. Crit Care 2004;8(1):25-32.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.
    1. Papazian L

    . Con: beta2-adrenergic agonists in ALI/ARDS: not recommended or potentially harmful? Am J Respir Crit Care Med 2011;184(5):504-506.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Perkins GD,
    2. McAuley DF

    . Pro: Beta-agonists in acute lung injury: the end of the story? Am J Respir Crit Care Med 2011;184(5):503-504.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Pesenti A,
    2. Pelosi P,
    3. Rossi N,
    4. Aprigliano M,
    5. Brazzi L,
    6. Fumagalli R

    . Respiratory mechanics and bronchodilator responsiveness in patients with the adult respiratory distress syndrome. Crit Care Med 1993;21(1):78-83.

    OpenUrlPubMedWeb of Science
13. 13.
    1. Morina P,
    2. Herrera M,
    3. Venegas J,
    4. Mora D,
    5. Rodriguez M,
    6. Pino E

    . Effects of nebulized salbutamol on respiratory mechanics in adult respiratory distress syndrome. Intensive Care Med 1997;23(1):58-64.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.
    1. O'Kane CM,
    2. McKeown SW,
    3. Perkins GD,
    4. Bassford CR,
    5. Gao F,
    6. Thickett DR,
    7. et al

    . Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med 2009;37(7):2242-2249.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Perkins GD,
    2. Nathani N,
    3. McAuley DF,
    4. Gao F,
    5. Thickett DR

    . In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury. Thorax 2007;62(1):36-42.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Gao Smith F,
    2. Perkins GD,
    3. Gates S,
    4. Young D,
    5. McAuley DF,
    6. Tunnicliffe W,
    7. et al

    . Effect of intravenous beta2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012;379(9812):229-235.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Matthay MA,
    2. Brower RG,
    3. Carson S,
    4. Douglas IS,
    5. Eisner M,
    6. Hite D,
    7. et al

    . Randomized, Placebo-controlled Clinical Trial of an Aerosolized beta(2)-Agonist for Treatment of Acute Lung Injury Am J Respir Crit Care Med 2011;184(5):561-568.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Perkins GD,
    2. McAuley DF,
    3. Thickett DR,
    4. Gao F

    . The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006;173(3):281-287.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Singh B,
    2. Erwin PJ,
    3. Moreno-Franco P

    . Beta-2-agonist in the treatment of acute lung injury: a meta-analysis (abstract). Crit Care Med 2012;40(12S):100-101.

    OpenUrl
20. 20.↵
    1. Moher D,
    2. Liberati A,
    3. Tetzlaff J,
    4. Altman DG

    . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.

    OpenUrlFREE Full Text
21. 21.↵
    1. Bernard GR,
    2. Artigas A,
    3. Brigham KL,
    4. Carlet J,
    5. Falke K,
    6. Hudson L,
    7. et al

    . The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818-824.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Schoenfeld DA,
    2. Bernard GR

    . Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002;30(8):1772-1777.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Mercat A,
    2. Richard JC,
    3. Vielle B,
    4. Jaber S,
    5. Osman D,
    6. Diehl JL,
    7. et al

    . Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008;299(6):646-655.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Cohen J

    . A Coefficient of agreement for nominal scales educational and psychological measurement. Educ Psychol Meas 1960;20(April):37-46.

    OpenUrlCrossRefWeb of Science
25. 25.↵
    1. Higgins JPT,
    2. Green S

    , editors. Cochrane handbook for systematic reviews of interventions, version 5.1.0, updated March 2011. The Cochrane Collaboration; 2011. http://handbook.cochrane.org. Accessed November 27, 2013.
26. 26.↵
    1. Higgins JP,
    2. Thompson SG,
    3. Deeks JJ,
    4. Altman DG

    . Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560.

    OpenUrlFREE Full Text
27. 27.↵
    1. Higgins JP,
    2. Thompson SG

    . Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21(11):1539-1558.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. DerSimonian R,
    2. Laird N

    . Meta-analysis in clinical trials. Control Clin Trials 1986;7(3):177-188.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    The Nordic Cochrane Centre; The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Cochrane Collaboration; 2011.
30. 30.↵
    1. Mitaka C,
    2. Hirata Y,
    3. Nagura T,
    4. Tsunoda Y,
    5. Amaha K

    . Beneficial effect of atrial natriuretic peptide on pulmonary gas exchange in patients with acute lung injury. Chest 1998;114(1):223-228.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.
    1. Jolliet P,
    2. Bulpa P,
    3. Ritz M,
    4. Ricou B,
    5. Lopez J,
    6. Chevrolet JC

    . Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome. Crit Care Med 1997;25(5):786-794.

    OpenUrlCrossRefPubMedWeb of Science
32. 32.
    1. Morelli A,
    2. Teboul JL,
    3. Maggiore SM,
    4. Vieillard-Baron A,
    5. Rocco M,
    6. Conti G,
    7. et al

    . Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006;34(9):2287-2293.

    OpenUrlCrossRefPubMedWeb of Science
33. 33.
    1. Bosma KJ,
    2. Taneja R,
    3. Lewis JF

    . Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches. Drugs 2010;70(10):1255-1282.

    OpenUrlCrossRefPubMedWeb of Science
34. 34.
    1. Papazian L,
    2. Bregeon F,
    3. Gaillat F,
    4. Thirion X,
    5. Roch A,
    6. Cortes E,
    7. et al

    . Inhaled NO and almitrine bismesylate in patients with acute respiratory distress syndrome: Effect of noradrenalin. Eur Respir J 1999;14(6):1283-1289.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    1. Cepkova M,
    2. Matthay MA

    . Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med 2006;21(3):119-143.

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    1. Erickson SE,
    2. Martin GS,
    3. Davis JL,
    4. Matthay MA,
    5. Eisner MD

    . Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med 2009;37(5):1574-1579.

    OpenUrlCrossRefPubMedWeb of Science
37. 37.↵
    1. Phua J,
    2. Badia JR,
    3. Adhikari NK,
    4. Friedrich JO,
    5. Fowler RA,
    6. Singh JM,
    7. et al

    . Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med 2009;179(3):220-227.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Erlich JM,
    2. Talmor DS,
    3. Cartin-Ceba R,
    4. Gajic O,
    5. Kor DJ

    . Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest 2011;139(2):289-295.

    OpenUrlCrossRefPubMedWeb of Science
39. 39.↵
    1. Kor DJ,
    2. Erlich J,
    3. Gong MN,
    4. Malinchoc M,
    5. Carter RE,
    6. Gajic O,
    7. et al

    . Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients. Crit Care Med 2011;39(11):2393-2400.

    OpenUrlPubMedWeb of Science
40. 40.↵
    1. Cuesta JM,
    2. Singer M

    . The stress response and critical illness: a review. Crit Care Med 2012;40(12):3283-3289.

    OpenUrlPubMed
41. 41.↵
    1. Cazzola M,
    2. Page CP,
    3. Calzetta L,
    4. Matera MG

    . Pharmacology and therapeutics of bronchodilators. Pharmacol Rev 2012;64(3):450-504.

    OpenUrlAbstract/FREE Full Text
42. 42.
    1. Scheinin M,
    2. Koulu M,
    3. Laurikainen E,
    4. Allonen H

    . Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Br J Clin Pharmacol 1987;24(5):645-653.

    OpenUrlPubMedWeb of Science
43. 43.↵
    1. Stratakos G,
    2. Kalomenidis J,
    3. Routsi C,
    4. Papiris S,
    5. Roussos C

    . Transient lactic acidosis as a side effect of inhaled salbutamol. Chest 2002;122(1):385-386.

    OpenUrlCrossRefPubMedWeb of Science
44. 44.↵
    1. Sterne JA,
    2. Gavaghan D,
    3. Egger M

    . Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53(11):1119-1129.

    OpenUrlCrossRefPubMedWeb of Science
45. 45.↵
    1. Ranieri VM,
    2. Rubenfeld GD,
    3. Thompson BT,
    4. Ferguson ND,
    5. Caldwell E,
    6. Fan E,
    7. et al

    . Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307(23):2526-2533.

    OpenUrlCrossRefPubMedWeb of Science
46. 46.↵
    1. Burns KE,
    2. Adhikari NK,
    3. Keenan SP,
    4. Meade MO

    . Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respiratory failure. Cochrane Database Syst Rev 2010(8):CD004127.